## DOCU: DocuSign, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.41 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($66.78)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. DocuSign: Fiscal Q3 Earnings Snapshot**
- Source: WHAS11 | 20251204T161300 | Bullish | Relevance: 100%
- DocuSign Inc. (DOCU) reported fiscal third-quarter net income of $83.7 million, or 40 cents per share, exceeding Wall Street expectations. Adjusted earnings were $1.01 per share. The company also surpassed revenue forecasts, posting $818.4 million for the quarter, and provided optimistic revenue guidance for the current quarter and full fiscal year.

**2. Docusign Announces Third Quarter Fiscal 2026 Financial Results**
- Source: PR Newswire | 20251204T160500 | Bullish | Relevance: 100%
- Docusign (NASDAQ: DOCU) announced strong financial results for its third quarter fiscal 2026, ending October 31, 2025, with revenue of $818.4 million, an 8% year-over-year increase, and non-GAAP diluted earnings per share of $1.01. The company highlighted growth in its Intelligent Agreement Management (IAM) platform, now serving over 25,000 customers, and provided optimistic guidance for the upcoming quarter and full fiscal year 2026.

**3. Docusign Inc (DOCU) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...**
- Source: Yahoo Finance | 20251204T090100 | Somewhat-Bullish | Relevance: 100%
- Docusign Inc (DOCU) reported strong Q3 2026 results with an 8% year-over-year revenue increase to $818 million and a 25% year-over-year free cash flow growth. The company achieved a non-GAAP operating margin of 31% and significantly expanded its Intelligent Agreement Management (IAM) platform customer base. Despite challenges like renewal timing variability and cloud migration costs impacting gross margin, Docusign provided optimistic guidance for both Q4 and fiscal year 2026 revenue and billings growth.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.01M) |
| Sells | 17 ($1.71M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.8% (-2.8%)
- Vanguard Group Inc: 10.8% (+1.1%)
- State Street Corpora: 4.0% (+0.5%)
- Jericho Capital Asse: 2.4% (0.0%)
- Capital World Invest: 2.1% (+0.2%)

### Key Risks

1. Long-term trend broken: trading 8.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.41 indicates undervaluation relative to growth. Insider selling cluster ($1.7M in 90 days), potential headwind. Institutional flow bearish (4 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.99 |
| 52W Range | $63.41 - $99.30 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.41 |
| Forward P/E | 17.3 |
| Current P/E | 18.8 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 0.2% to 2.6% (+2.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 4.7% shows strong absolute momentum above own 20MA. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (0.69), confirming momentum. RSI neutral at 57. Elevated volume (2.0x 20MA), institutional activity likely. OFD pattern: -DUH (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.59% (CS: 71) | Neutral |
| RSI_14 | 57.4 | Neutral |
| MACD Histogram | 0.69 | Bullish |
| vs SMA20 | 1.047x | Above |
| vs SMA50 | 1.015x | Above |
| vs SMA200 | 0.920x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $71.10
- **Stop Loss:** $66.78 (6.1% risk)
- **Target:** $79.74 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 231
- **Position Value:** $16,424.10
- **Portfolio %:** 16.42%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-03-12 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.92 | $1.01 | +10.3% |
| 2025Q3 | $0.85 | $0.92 | +8.6% |
| 2025Q2 | $0.81 | $0.90 | +10.4% |
| 2025Q1 | $0.85 | $0.86 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*